IRIS
DI TARANTO, MARIA DONATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.657
NA - Nord America 3.067
EU - Europa 2.540
SA - Sud America 436
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 9.799
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.908
SG - Singapore 1.630
RU - Federazione Russa 1.105
CN - Cina 718
VN - Vietnam 670
IT - Italia 613
BR - Brasile 350
HK - Hong Kong 256
DE - Germania 157
FR - Francia 151
NL - Olanda 132
CA - Canada 97
BD - Bangladesh 83
GB - Regno Unito 74
FI - Finlandia 69
IN - India 59
IE - Irlanda 49
JP - Giappone 47
CI - Costa d'Avorio 41
MX - Messico 38
AR - Argentina 34
SE - Svezia 34
UA - Ucraina 33
KR - Corea 31
ZA - Sudafrica 23
IQ - Iraq 22
PL - Polonia 22
TH - Thailandia 22
AT - Austria 19
PH - Filippine 19
ES - Italia 14
CO - Colombia 13
PK - Pakistan 13
EC - Ecuador 12
ID - Indonesia 10
RO - Romania 10
NP - Nepal 9
AE - Emirati Arabi Uniti 8
KE - Kenya 8
TW - Taiwan 8
BE - Belgio 7
CH - Svizzera 7
PY - Paraguay 7
TR - Turchia 7
VE - Venezuela 7
LT - Lituania 6
MA - Marocco 6
SA - Arabia Saudita 6
CZ - Repubblica Ceca 5
JM - Giamaica 5
JO - Giordania 5
MY - Malesia 5
PE - Perù 5
AL - Albania 4
CR - Costa Rica 4
LV - Lettonia 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
IL - Israele 3
LB - Libano 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
UY - Uruguay 3
UZ - Uzbekistan 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
HN - Honduras 2
HR - Croazia 2
KZ - Kazakistan 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AU - Australia 1
BS - Bahamas 1
BW - Botswana 1
CM - Camerun 1
CY - Cipro 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KY - Cayman, isole 1
MD - Moldavia 1
ME - Montenegro 1
Totale 9.783
Salva come PNG Salva come JPEG
Città #
Singapore 829
San Jose 580
Ashburn 275
Moscow 239
Hong Kong 233
Beijing 229
Chandler 223
Ho Chi Minh City 203
Hefei 135
Hanoi 126
Naples 119
Santa Clara 118
Los Angeles 100
Amsterdam 92
Lauterbourg 80
The Dalles 71
Napoli 67
Millbury 66
New York 57
Boardman 47
Boston 46
São Paulo 44
Princeton 41
Tokyo 41
Nanjing 40
Buffalo 39
Haiphong 35
Ottawa 33
Rome 33
Des Moines 32
Milan 32
Dallas 31
Munich 31
Lawrence 27
Redondo Beach 27
Council Bluffs 26
Dong Ket 26
Nuremberg 26
Toronto 24
Frankfurt am Main 23
Helsinki 23
Da Nang 22
Orem 22
Seattle 21
Seoul 21
Brooklyn 18
Denver 18
Dublin 18
Warsaw 18
Montreal 17
Wilmington 17
Mexico City 16
Rio de Janeiro 15
Washington 15
Woodbridge 15
Chennai 14
Jacksonville 14
Nanchang 13
Stockholm 13
Bangkok 12
Chicago 12
Hải Dương 12
San Francisco 12
Augusta 11
Brasília 11
Johannesburg 11
Poplar 11
Shenyang 11
Bologna 10
Houston 10
London 10
Redwood City 10
Timisoara 10
Baghdad 9
Falkenstein 9
Norwalk 9
Shanghai 9
Biên Hòa 8
Charlotte 8
Curitiba 8
Düsseldorf 8
Ercolano 8
Manchester 8
Nairobi 8
Portsmouth 8
Turku 8
Brussels 7
Cercola 7
Hebei 7
Ninh Bình 7
Tianjin 7
Belo Horizonte 6
City of London 6
Dhaka 6
Mumbai 6
Palermo 6
Phoenix 6
Secaucus 6
Thái Bình 6
Vienna 6
Totale 5.226
Salva come PNG Salva come JPEG
Nome #
Galectin-3 and Lp(a) plasma concentrations and advanced carotid atherosclerotic plaques: correlation with plaque presence and features 181
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 168
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 164
A case of cerebrotendinous xanthomatosis in a woman with a normal cholesterolemia. 156
A wide next-generation-sequencing panel improves the molecular diagnosis of dyslipidemias 154
Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement 150
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 148
Decreased Paraoxonase-2 Expression in Human Carotids During the Progression of Atherosclerosis 147
Expression of inflammation-related genes in human atherosclerotic plaques. 144
Identification and functional characterization of a new mutation leading to defective uptake of LDL-LDLR complex. 143
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 143
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study 141
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 138
A case of cerebrotendinous xantomatosis in a woman with a normal colesterolemia 137
Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy 135
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 134
Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia 133
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 132
Lipid profile and genetic status in a familial hypercholesterolemia pediatric population: exploring the LDL/HDL ratio 131
A case of Cerebrotendinous Xanthomatosis with spinal cord involvement and without tendon xanthomas: identification of a new mutation of the CYP27A1 gene 131
Carotid Endarterectomy versus Carotid Artery Stenting with Double-Layer Micromesh Carotid Stent: contemporary results of a single-center retrospective study 131
Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. 130
Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia 129
Identification of deletions in LDLR gene by Multiplex Ligation-Dependent Probe Amplification Analysis. 129
New insights into the management of homozygous familial hypercholesterolemia patients treated with lomitapide: a single-center experience 128
Evinacumab for Homozygous Familial Hypercholesterolemia: The Italian Cohort of the ELIPSE HoFH Study 127
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 126
A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia 126
Identification of Single Nucleotide Polymorphisms associated to Familial Combined Hyperlipidemia. 125
Expression of inflammation-related genes in human atherosclerotic plaque. 125
An improved method on stimulated T-lymphocytes to functionally characterize novel and known LDLR mutations. 125
Familial hypercholesterolemia: A complex genetic disease with variable phenotypes 125
Relazione tra polimorfismi del gene paraoxonasi ed ischemia miocardica indotta da stress in pazienti con sospetta malattia coronarica 124
Familial hypercholesterolemia: a flow chart for the molecular diagnosis. 123
Calprotectin Levels and Neutrophil Count Are Prognostic Markers of Mortality in COVID-19 Patients 122
Investigation of Single Nucleotide Polymorphisms Associated to Familial Combined Hyperlipidemia with Random Forests. 122
Changes in carotid stiffness in patients with familial hypercholesterolemia treated with Evolocumab®: A prospective cohort study 122
Familial Combined Hyperlipidemia: identification of misdiagnosed patients by detection of LDLR mutations. 121
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 120
Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis 118
Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population. 118
Age-related changes of cholestanol and lathosterol plasma concentrations: An explorative study 118
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy 117
Simplified Criteria for Identification of Familial Hypercholesterolemia in Children: Application in Real Life 116
Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study 116
Assessment of Platelet Aggregation and Thrombin Generation in Patients with Familial Chylomicronemia Syndrome Treated with Volanesorsen: A Cross-Sectional Study 116
SMALL DENSE LDL IN RELATION TO CHANGES IN OXIDATION MARKERS AND VASCULAR REACTIVITYIN PATIENTS WITH HYPERCHOLESTEROLEMIA TREATED WITH EVOLOCUMAB: A PROSPECTIVE COHORT STUDY 116
Targeting Nanostrategies for Imaging of Atherosclerosis 115
Association of Very Rare NOTCH2 Variants with Clinical Features of Alagille Syndrome 114
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 113
Correlation between low adenosine A2A receptor expression and hypercholesterolemia: A new component of the cardiovascular risk? 113
The role of immunosuppressive therapy in aneurysmal degeneration of hemodialysis fistulas in renal transplant patients: Aneurysmatic arteriovenous fistula in transplant patients 113
A first comparative study on two cell colture techniques – stimulated T cells and continous lymphoblastoid cell lines – in the detection of LDL receptor residual activity versus molecular genetic analysys 112
Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports 112
EXPRESSION OF ADIPONECTIN RECEPTORS IN HUMAN CAROTID ATHEROSCLEROTIC PLAQUES Abstracts from the 12th National Congress of the Italian Society of Cardiovascular Prevention (SIPREC), Naples, 6–8 March 2014 111
Identificazione e caratterizzazione funzionale di mutazioni nel gene LDLR in pazienti del sud Italia affetti da Ipercolesterolemia familiare. 110
The novel variant p.Ser465Leu in the PCSK9 gene does not account for the decreased LDLR activity in members of a FH family 110
Characterization of two novel pathogenic variants at compound heterozygous status in lipase maturation factor 1 gene causing severe hypertriglyceridemia 110
ECHOCARDIOGRAFIC ANDECO-DOPPLER ABNORMALITIESIN RELATION TO LDL CHOLESTEROLIN FAMILIAL HYPERCHOLESTEROLEMIA 108
Advances in Computational Methods for Genetic Diseases 106
Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: Integration and evolution of genetic diagnosis 105
Lipoprotein (a) is an independent predictor of cardiovascular events in Mediterranean women (Progetto Atena) 104
Homozygous Familial Hypercholesterolemia in Campania 103
Polymorphisms and the expression of genes encoding enzymes involved in cardiovascular diseases 103
Identification of single nucleotide polymorphisms associated to familial combined hyperlipidemia 102
MANAGEMENT OF SEVEREHYPERCHOLESTEROLEMIA IN A FAMILYBEARING C.974G>A LDL RECEPTORMUTATION 101
Altered expression of inflammation-related genes in human carotid atherosclerotic plaques. 101
Molecular diagnosis of Familial Hypercholesterolemia: the utility of a country specific protocol. 99
IDENTIFICATION OF LDLR MUTATIONSIN PATIENTS WITH FAMILIAL COMBINEDHYPERLIPIDEMIA 97
Identification of deletions in LDRR gene by multiplex ligation-dependent probe amplification analysis 92
IDENTIFICATION AND FUNCTIONALCHARACTERIZATION OF A NEW MUTATIONLEADING TO DEFECTIVE UPTAKEOF LDL-LDLR COMPLEX 92
Endovascular Treatment Versus Medical Therapy for Hypertensive Patients with Renal Artery Stenosis: An Updated Systematic Review 89
C-reactive protein levels are associated with paraoxonase polymorphism L55M in patients undergoing cardiac SPECT imaging 87
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group 85
The role of galectin-3 and LP(A) in atherosclerosis: A combined analysis of serum levels and plaque characteristics 85
Association between Inguinal Hernia and Arterial Disease: A Preliminary Report 85
The Arg499His gain-of-function mutation in the C-terminal domain of PCSK9 83
Metalloproteinases between History, Health, Disease, and the Complex Dimension of Social Determinants of Health 81
Valutazione di parametri di ossidazione in placche aterosclerotiche e plasma di pazienti endoarteriectomizzati. 78
Galectin-3 in cardiovascular diseases 69
Harnessing the potential of metalloproteinases in extracellular vesicles: a window of opportunity for aneurysm management 68
Identification and in vitro characterization of two new PCSK9 Gain of Function variants found in patients with Familial Hypercholesterolemia 63
The Impact of Chronic Kidney Disease on Peripheral Artery Disease and Peripheral Revascularization 62
Clinical and Pathological Correlations in Chronic Venous Disease 61
Multiparametric platform for profiling lipid trafficking in human leukocytes 53
Statistical and Computational Methods for Genetic Diseases: An Overview 51
Studio del miRNome e caratterizzazione funzionale del LDLR per l’identificazione di nuove cause molecolari dell’ipercolesterolemia familiare [miRNome study and functional characterization of LDLR for the identification of new molecular causes of Familial Hypercholesterolemia] 50
Genetic Assessment and Clinical Correlates in Severe Hypertriglyceridemia: A Systematic Review 18
A delayed diagnosis of familial chylomicronemia syndrome in an elderly patient: Clinical implications of late-onset disease 6
Diagnosis of Familial Hypercholesterolemia in Children: From Clinical Features Through Gene Variants to Polygenic Score 5
Totale 9.950
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.450
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022423 21 5 2 14 14 22 7 17 32 15 116 158
2022/2023573 72 23 24 26 91 70 3 57 87 85 29 6
2023/2024503 30 69 40 35 28 49 12 70 4 20 76 70
2024/20252.583 115 117 22 90 61 157 267 177 162 265 942 208
2025/20265.201 599 338 471 444 902 223 624 235 661 357 186 161
2026/202746 46 0 0 0 0 0 0 0 0 0 0 0
Totale 9.950